Dinesh Patel
Chief Executive Officer chez PROTAGONIST THERAPEUTICS, INC.
Fortune : 16 M $ au 31/03/2024
Postes actifs de Dinesh Patel
Sociétés | Poste | Début | Fin |
---|---|---|---|
PROTAGONIST THERAPEUTICS, INC. | Chief Executive Officer | 01/12/2008 | - |
Director/Board Member | 01/12/2008 | - | |
President | 01/12/2008 | - | |
Comptroller/Controller/Auditor | 20/03/2019 | 28/05/2019 | |
Director of Finance/CFO | 11/01/2019 | 28/05/2019 | |
Protagonist Pty Ltd.
Protagonist Pty Ltd. Pharmaceuticals: MajorHealth Technology Protagonist Pty Ltd. operates as a clinical-stage biopharmaceutical company. Its proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The company was founded on September 19, 2001 and is headquartered in Brisbane, Australia. | Director/Board Member | 01/12/2008 | - |
Chief Executive Officer | 06/07/2009 | - | |
President | 06/07/2009 | - |
Historique de carrière de Dinesh Patel
Anciens postes connus de Dinesh Patel
Sociétés | Poste | Début | Fin |
---|---|---|---|
Arête Therapeutics, Inc.
Arête Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Arête Therapeutics, Inc. develops and commercializes molecule drugs to treat cardiovascular and inflammatory diseases. It focuses on developing AR9281, an orally-administered compound that inhibits s-EH (soluble epoxide hydrolase), an enzyme that plays a key role in the metabolism of arachidonic acid. It also focuses on testing various back-up candidates as additional first-in-class anti-hypertensive plus agents. The company was founded in 2003 and is headquartered in Hayward, CA. | Chief Executive Officer | 01/01/2006 | 01/01/2008 |
President | 01/01/2006 | 01/01/2008 | |
Miikana Therapeutics, Inc.
Miikana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Miikana Therapeutics, Inc. develops therapeutics for the treatment of cancer and inflammatory diseases. It is a biopharmaceutical company focused on development and discovery of novel oncology drugs. It also performs its own research and licenses other companies. The company was founded in 2002 by Tak Mak, Dinesh Patel and S. Gail Eckhardt and is headquartered in Fremont, CA. | Chief Executive Officer | 01/01/2003 | 01/01/2005 |
Founder | 01/01/2003 | 01/01/2005 | |
President | 01/01/2003 | 01/01/2005 | |
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | Corporate Officer/Principal | 01/01/1996 | 01/01/2003 |
AFFYMAX, INC. | Corporate Officer/Principal | 01/01/1993 | 01/01/1996 |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/1985 | 01/01/1993 |
Formation de Dinesh Patel
Rutgers State University of New Jersey | Doctorate Degree |
Sardar Patel University | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 8 |
Australie | 2 |
Inde | 2 |
Opérationnelle
Chief Executive Officer | 4 |
President | 4 |
Corporate Officer/Principal | 3 |
Sectorielle
Health Technology | 8 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
AFFYMAX, INC. | Health Technology |
PROTAGONIST THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 4 |
---|---|
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | Health Technology |
Miikana Therapeutics, Inc.
Miikana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Miikana Therapeutics, Inc. develops therapeutics for the treatment of cancer and inflammatory diseases. It is a biopharmaceutical company focused on development and discovery of novel oncology drugs. It also performs its own research and licenses other companies. The company was founded in 2002 by Tak Mak, Dinesh Patel and S. Gail Eckhardt and is headquartered in Fremont, CA. | Health Technology |
Arête Therapeutics, Inc.
Arête Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Arête Therapeutics, Inc. develops and commercializes molecule drugs to treat cardiovascular and inflammatory diseases. It focuses on developing AR9281, an orally-administered compound that inhibits s-EH (soluble epoxide hydrolase), an enzyme that plays a key role in the metabolism of arachidonic acid. It also focuses on testing various back-up candidates as additional first-in-class anti-hypertensive plus agents. The company was founded in 2003 and is headquartered in Hayward, CA. | Health Technology |
Protagonist Pty Ltd.
Protagonist Pty Ltd. Pharmaceuticals: MajorHealth Technology Protagonist Pty Ltd. operates as a clinical-stage biopharmaceutical company. Its proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The company was founded on September 19, 2001 and is headquartered in Brisbane, Australia. | Health Technology |
- Bourse
- Insiders
- Dinesh Patel
- Expérience